LTIP274A - Neuromuscular blocking agents - Google Patents

Neuromuscular blocking agents

Info

Publication number
LTIP274A
LTIP274A LTIP274A LTIP274A LTIP274A LT IP274 A LTIP274 A LT IP274A LT IP274 A LTIP274 A LT IP274A LT IP274 A LTIP274 A LT IP274A LT IP274 A LTIP274 A LT IP274A
Authority
LT
Lithuania
Prior art keywords
cis
geometrical
isomer
neuromuscular blocking
optical isomers
Prior art date
Application number
LTIP274A
Inventor
Derek Anthony Hill
Geoffrey Lloyd Turner
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of LTIP274A publication Critical patent/LTIP274A/en
Publication of LT3317B publication Critical patent/LT3317B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Led Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1R-$i(cis),1'R-$i(cis) isomer of a 2',2'-(3,11-dioxo-4,10-dioxatridecylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium) salt, substantially free from other geometrical and optical isomers thereof. The 1R-$i(cis),1'R-$i(cis) isomer has been found to have an advantageous combination of pharmacological properties, notably greater neuromuscular blocking potency, weaker histamine-releasing potency, and at equivalent levels of neuromuscular blockage, fewer potential adverse effects on the autonomic nervous system (sympathetic and parasympathetic blockade), in comparison with the known mixture of geometrical and optical isomers.
LTIP274A 1990-07-13 1992-12-30 Neuromuscular blocking agents LT3317B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015473A GB9015473D0 (en) 1990-07-13 1990-07-13 Neuromuscular blocking agents

Publications (2)

Publication Number Publication Date
LTIP274A true LTIP274A (en) 1994-10-25
LT3317B LT3317B (en) 1995-06-26

Family

ID=10679071

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP274A LT3317B (en) 1990-07-13 1992-12-30 Neuromuscular blocking agents

Country Status (40)

Country Link
EP (1) EP0539470B1 (en)
JP (3) JP2823356B2 (en)
KR (1) KR0174284B1 (en)
AT (1) ATE138369T1 (en)
AU (2) AU8190491A (en)
BE (1) BE1003407A3 (en)
CA (1) CA2087104C (en)
CH (1) CH683427A5 (en)
CY (1) CY1985A (en)
CZ (1) CZ284645B6 (en)
DE (2) DE69119768T2 (en)
DK (2) DK0539470T3 (en)
ES (2) ES2083315B1 (en)
FI (2) FI982342A7 (en)
FR (1) FR2665701B1 (en)
GB (2) GB9015473D0 (en)
GE (1) GEP19981163B (en)
GR (1) GR3020792T3 (en)
HK (1) HK80196A (en)
HU (2) HU218766B (en)
IE (1) IE912440A1 (en)
IL (1) IL98814A (en)
IT (1) IT1249677B (en)
LT (1) LT3317B (en)
LU (1) LU88198A1 (en)
LV (1) LV10432B (en)
MX (1) MX9203220A (en)
MY (1) MY113017A (en)
NL (1) NL9120017A (en)
NZ (1) NZ238964A (en)
PA (1) PA8401801A1 (en)
PL (1) PL167302B1 (en)
PT (1) PT98306B (en)
RU (1) RU2104005C1 (en)
SA (1) SA91120073B1 (en)
SE (1) SE9300052D0 (en)
SK (1) SK279907B6 (en)
UA (1) UA32536C2 (en)
WO (1) WO1992000965A1 (en)
ZA (1) ZA915468B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
DE19535762A1 (en) * 1995-09-26 1997-03-27 Basf Ag Racemate resolution process
US5684154A (en) * 1996-02-16 1997-11-04 Abbott Laboratories Process for the preparation and isolation of atracurium besylate
CN1203061C (en) 1997-03-25 2005-05-25 艾弗拉药品公司 Substituted isoquinolines, process for their preparation, pharmaceutical compositions and their use in medicaments
AU2008222298A1 (en) 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
EP2125743A1 (en) * 2007-03-26 2009-12-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US8293912B2 (en) 2007-05-01 2012-10-23 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
CA2685488A1 (en) 2007-05-01 2008-11-06 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
CA2687157A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
CN101337936B (en) * 2007-07-06 2011-03-23 江苏恒瑞医药股份有限公司 Method for purifying atracurium besylate by column chromatography
CN101337935B (en) * 2007-07-06 2011-01-12 江苏恒瑞医药股份有限公司 Method for purifying atracurium besylate by two-phase extraction
CA2702535A1 (en) 2007-10-29 2009-05-07 Chemagis Ltd. Novel r,r'-atracurium salts
IT1396543B1 (en) 2008-07-16 2012-12-14 Farmabios Spa PROCESS FOR PURIFICATION OF NEUROMUSCULAR BLOCKS
WO2010128518A2 (en) * 2009-05-04 2010-11-11 Gland Pharma Limited Novel process for the preparation of cisatracurium besylate
CN107056700A (en) * 2017-04-18 2017-08-18 哈尔滨医科大学 A kind of Resolution method of tetrahydroisoquinolicompounds compounds racemic modification
CN112939862B (en) * 2021-02-03 2023-01-10 江苏诚信药业有限公司 Separation preparation method and application of cisatracurium besilate impurity H
CN115850169B (en) * 2022-10-17 2025-04-04 上海医药集团(本溪)北方药业有限公司 Preparation method of cisatracurium besylate impurities and intermediates thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
GB1579822A (en) * 1976-10-29 1980-11-26 Wellcome Found Tetrahydroisoquinolinium muscle relaxants
ES454090A1 (en) * 1976-12-09 1978-01-16 Wellcome Found A method for preparing heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
DE3328664A1 (en) * 1983-08-09 1985-02-21 Robert Bosch Gmbh, 7000 Stuttgart SUGAR DRAWER
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
US9524531B2 (en) 2011-05-09 2016-12-20 Microsoft Technology Licensing, Llc Extensibility features for electronic communications

Also Published As

Publication number Publication date
EP0539470B1 (en) 1996-05-22
IL98814A0 (en) 1992-07-15
ITRM910518A0 (en) 1991-07-12
ES2083315A1 (en) 1996-04-01
SK383392A3 (en) 1999-05-07
GB9224764D0 (en) 1993-02-03
FR2665701A1 (en) 1992-02-14
AU1134695A (en) 1995-03-30
JP2823356B2 (en) 1998-11-11
PA8401801A1 (en) 1997-01-03
LV10432B (en) 1995-08-20
IL98814A (en) 1995-12-08
HU218766B (en) 2000-11-28
PT98306B (en) 1999-01-29
AU8190491A (en) 1992-02-04
BE1003407A3 (en) 1992-03-17
MY113017A (en) 2001-11-30
LV10432A (en) 1995-02-20
DE4191541T1 (en) 1993-05-13
FI982342A0 (en) 1998-10-28
GB9015473D0 (en) 1990-08-29
SE9300052L (en) 1993-01-12
DK149692A (en) 1992-12-14
HU9300052D0 (en) 1993-04-28
EP0539470A1 (en) 1993-05-05
DK149692D0 (en) 1992-12-14
FI982342L (en) 1998-10-28
FI103507B1 (en) 1999-07-15
ZA915468B (en) 1993-03-31
JPH05508648A (en) 1993-12-02
WO1992000965A1 (en) 1992-01-23
JPH10139763A (en) 1998-05-26
SA91120073B1 (en) 2002-10-26
SE9300052D0 (en) 1993-01-12
FI925894L (en) 1992-12-28
PL297606A1 (en) 1992-07-13
CA2087104C (en) 1998-08-18
CZ284645B6 (en) 1999-01-13
NZ238964A (en) 1992-06-25
LT3317B (en) 1995-06-26
GEP19981163B (en) 1998-07-06
HK80196A (en) 1996-05-17
FI103507B (en) 1999-07-15
CH683427A5 (en) 1994-03-15
DK0539470T3 (en) 1996-08-05
FI982342A7 (en) 1998-10-28
ATE138369T1 (en) 1996-06-15
PT98306A (en) 1992-06-30
RU2104005C1 (en) 1998-02-10
GB2260763A (en) 1993-04-28
ES2083315B1 (en) 1997-11-16
JP2001058981A (en) 2001-03-06
GR3020792T3 (en) 1996-11-30
UA32536C2 (en) 2001-02-15
JP3462165B2 (en) 2003-11-05
IT1249677B (en) 1995-03-09
FR2665701B1 (en) 1995-03-03
ES2088009T3 (en) 1996-08-01
KR0174284B1 (en) 1999-02-18
IE912440A1 (en) 1992-01-15
NL9120017A (en) 1993-04-01
DE69119768D1 (en) 1996-06-27
CZ383392A3 (en) 1994-02-16
DE69119768T2 (en) 1996-10-02
HUT67613A (en) 1995-04-28
HU211169A9 (en) 1995-11-28
CY1985A (en) 1997-09-05
AU687481B2 (en) 1998-02-26
SK279907B6 (en) 1999-05-07
CA2087104A1 (en) 1992-01-14
ITRM910518A1 (en) 1993-01-12
GB2260763B (en) 1994-01-05
LU88198A1 (en) 1993-05-17
MX9203220A (en) 1992-07-01
FI925894A0 (en) 1992-12-28
PL167302B1 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
GB2260763B (en) Neuromuscular blocking agents
EA199800357A1 (en) PHARMACEUTICAL ANGIOSTATIC DIPEPTIDE COMPOSITIONS AND METHODS OF THEIR APPLICATION
HU907011D0 (en) Process for producing preparatives containing sertralines
RU93004869A (en) NERVOUS MUSCLE BLOCKER, ITS PREPARATION, PHARMACEUTICAL COMPOSITION AND METHOD OF ENSURING NERVOUS MUSCLE BLOCKING ANIMALS
AU9057191A (en) N-substituted lactams useful as cholecystokinin antagonists
UA42819C2 (en) INJECTION AND INFUSION SOLUTION CONTAINING ENROFLOXACIN
DE69522578D1 (en) GLIAL NEUROTROPHER FACTOR AS A NERVOUS PROTECTION AGENT
NO970946D0 (en) Mixture to prevent pain containing a non-narcotic analgesic and an analgesia enhancer
MXPA04004826A (en) Chemokine receptor antagonists and methods of use thereof.
UA42730C2 (en) Tetrahydroisoquinoline derivatives, pharmaceutically acceptable salts thereof in the form individual enantiomers, racemats or other mixtures of enantiomers
YU40398A (en) A composition of nasal spray for administering a remedy for curing a delayed emesis fit
EP0135189A3 (en) Pharmaceutically useful malonamides
IL111246A0 (en) Tricyclic compounds and pharmaceutical compositions containing them
范谨之 et al. The Antagonized Effect of Phentolamine on Endogenous Opiate-Like Substances
MY106292A (en) (alpha)-adrenergic receptor antagonists.

Legal Events

Date Code Title Description
MK9A Expiry of a patent

Effective date: 20121230